Skip to main content
Premium Trial:

Request an Annual Quote

RIKEN Omics Science Center to Expand Sequencing Facility with $17M in Government Funding


The RIKEN Omics Science Center plans to update and expand its DNA sequencing infrastructure with $17 million in new grant funding from the Japanese government, the center said earlier this month.

Following the expansion, "OSC will assume the role of Japan's primary national sequencing center," according to a statement issued by the center.

OSC, which is based in the RIKEN Yokohama Institute and opened its doors last year, received the funding from the Japanese Ministry of Education, Culture, Sports, Science, and Technology to build a sequencing center for the Cell Innovation Project, which aims to study cell function by next-generation sequencing.

Another $10 million went to the National Institute of Genetics in Mishima, which will serve as the data analysis center for the project, to expand its data storage and analysis capacity.

The OSC plans to use the funding to add several types of instruments. "We are not focusing on any particular sequencing platform because we are expected to provide sequencing services on demand from the users," an OSC spokesperson told In Sequence by e-mail.

However, the center, whose scientists developed a method called Cap Analysis of Gene Expression, is particularly interested in single-molecule sequencing technology in order to avoid PCR-induced bias in CAGE studies. "Therefore, we will likely purchase one or more single-molecule sequencers for this purpose," according to the spokesperson.

A year ago, OSC Director Yoshihide Hayashizaki told In Sequence that the center was thinking of acquiring a Helicos Genetic Analysis system, the first commercially available single-molecule sequencer.

Other options for single-molecule sequencing will become available next year as Pacific Biosciences plans to commercialize its real-time single-molecule sequencer during the second half of 2010.

At present, OSC has one Roche/454 Genome Sequencer FLX running Titanium chemistry, two Illumina Genome AnalyzerII systems, and two Applied Biosystems SOLiD 3 sequencers installed, in addition to three ABI 3730xl, one ABI 3100, and one Shimadzu DeNova Sanger sequencer.

Under the Cell Innovation Project, seven research programs will focus on different aspects of cellular function, such as in the context of cancer and developmental biology. They will closely collaborate with the OSC sequencing center and the National Institute of Genetics data center under the program.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.